Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road (original) (raw)

• Shiga, K. The trend of prevention, therapy and epidemiology of dysentery since the discovery of its causative organism. N. Eng. J. Med. 215, 1205–1211 (1936). Musings on a lifetime of study of Shigella infections by the discoverer of this pathogen.
  Article Google Scholar
• Shiga, K. Über den Dysenteribacillus (Bacillus dysenteriae). Zentrablatt für Bakteriologie, Parasitenkunde u. Infektionskrankheiten. Erste Abteilung: Medicinisch-hygienische. Bakteriologie und tierische Parasitenkunde 24, 817–818 (1898).
  Google Scholar
• Yabuuchi, E. Bacillus dysentericus (sic) 1897 was the first taxonomic rather than Bacillus dysenteriae 1898. Int. J. Syst. Evol. Microbiol. 52, 1041 (2002).
  PubMed Google Scholar
• Strockbine, N. A. & Maurelli, A. T. in Bergey's Manual of Systematic Bacteriology (eds. Brenner, D. J., Krieg, N. R. & Staley, T. E.) 811–823 (Springer, New York, 2005).
  Google Scholar
• Kotloff, K. L. et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. World Health Organ. 77, 651–666 (1999). A review of the epidemiological importance of Shigella infections.
  CAS PubMed PubMed Central Google Scholar
• Ferreccio, C. et al. Epidemiologic patterns of acute diarrhea and endemic Shigella infections in a poor periurban setting in Santiago, Chile. Am. J. Epidemiol. 134, 614–627 (1991). The epidemiological study of paediatric shigellosis shows that under natural conditions of exposure, a prior clinical Shigella infection confers ∼72% protection against subsequent disease upon exposure to a homologous serotype.
  Article CAS PubMed Google Scholar
• von Seidlein L. et al. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. Plos. Med. 3, e353 (2006).
  Article PubMed PubMed Central Google Scholar
• Dutta, P. et al. Assessing the cause of in-patients pediatric diarrheal deaths: an analysis of hospital records. Indian Pediatr. 32, 313–321 (1995).
  CAS PubMed Google Scholar
• Brooks, J. T. et al. Epidemiology of sporadic bloody diarrhea in rural Western Kenya. Am. J. Trop. Med. Hyg. 68, 671–677 (2003).
  Article PubMed Google Scholar
• Fulla, N., Prado, V., Duran, C., Lagos, R. & Levine, M. M. Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of Santiago, Chile. Am. J. Trop. Med. Hyg. 72, 851–854 (2005).
  Article PubMed Google Scholar
• Mata, L., Gangarosa, E., Caceres, A., Perera, D. & Mejicanos, M. Epidemic Shiga bacilllus dysentery in Central America. I. Etiologic investigations in Guatemala, 1969. J. Infect. Dis. 122, 170–180 (1970). Epidemiological and microbiological studies at the onset of the Central American pandemic of Shiga dysentery in the late 1960s.
  Article CAS PubMed Google Scholar
• Rahaman, M. M., Khan, M. M., Aziz, K. M. S., Islam, M. S. & Kibriya, A. K. An outbreak of dysentery caused by Shigella dysenteriae type 1 on a Coral Island in the Bay of Bengal. J. Infect. Dis. 132, 15–19 (1975).
  Article CAS PubMed Google Scholar
• Ebright, J. R. et al. Epidemic Shiga bacillus dysentery in Central Africa. Am. J. Trop. Med. Hyg. 33, 1192–1197 (1984).
  Article CAS PubMed Google Scholar
• Aragon, M., Barreto, A., Chambule, J., Noya, A. & Tallarico, M. Shigellosis in Mozambique: the 1993 outbreak rehabilitation — a follow-up study. Trop. Doct. 25, 159–162 (1995).
  Article CAS PubMed Google Scholar
• Birmingham, M. E., Lee, L. A., Ntakibirora, M., Bizimana, F. & Deming, M. S. A household survey of dysentery in Burundi: implications for the current pandemic in sub-Saharan Africa. Bull. World Health Organ. 75, 45–53 (1997).
  CAS PubMed PubMed Central Google Scholar
• Shane, A. L., Tucker, N. A., Crump, J. A., Mintz, E. D. & Painter, J. A. Sharing Shigella: risk factors for a multicommunity outbreak of shigellosis. Arch. Pediatr. Adolesc. Med. 157, 601–603 (2003).
  Article PubMed Google Scholar
• Mohle-Boetani, J. C. et al. Communitywide shigellosis: control of an outbreak and risk factors in child day-care centers. Am. J. Public Health. 85, 812–816 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Hyams, K. C. et al. Diarrheal disease during Operation Desert Shield. N. Engl. J. Med. 325, 1423–1428 (1991).
  Article CAS PubMed Google Scholar
• Levine, M. M. Immunization against bacterial diseases of the intestine. J. Pediatr. Gastroenterol. Nutr. 31, 336–355 (2000).
  Article CAS PubMed Google Scholar
• Cossart, P. & Sansonetti, P. J. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 304, 242–248 (2004).
  Article CAS PubMed Google Scholar
• Phalipon, A. & Sansonetti, P. J. Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? Immunol. Cell Biol. 85, 119–129 (2007).
  Article CAS PubMed Google Scholar
• Levine, M. M. et al. Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J. Infect. Dis. 127, 261–270 (1973).
  Article CAS PubMed Google Scholar
• DuPont, H. L., Hornick, R. B., Dawkins, A. T., Snyder, M. J. & Formal, S. B. The response of man to virulent Shigella flexneri 2a. J. Infect. Dis. 119, 296–299 (1969).
  Article CAS PubMed Google Scholar
• Herrington, D. A. et al. Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi–Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. Vaccine 8, 353–357 (1990).
  Article CAS PubMed Google Scholar
• Kotloff, K. L. et al. A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. Vaccine 13, 1488–1494 (1995). Administering Shigella with bicarbonate buffer in the volunteer model assures a consistent infection rate. Volunteers who experienced shigellosis showed ∼70% protection against disease upon re-challenge compared with controls.
  Article CAS PubMed Google Scholar
• DuPont, H. L., Levine, M. M., Hornick, R. B. & Formal, S. B. Inoculum size in shigellosis and implications for expected mode of transmission. J. Infect. Dis. 159, 1126–1128 (1989). Reviews early volunteer studies showing that shigellosis can result from the ingestion of small inocula.
  Article CAS PubMed Google Scholar
• Levine, M. M. et al. Studies with a new generation of oral attenuated Shigella vaccine: Escherichia coli bearing surface antigens of Shigella flexneri. J. Infect. Dis. 136, 577–582 (1977). An E. coli hybrid expressing S. flexneri 2a O-antigens failed to protect against S. flexneri 2a challenge.
  Article CAS PubMed Google Scholar
• Coster, T. S. et al. Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602. Infect. Immun. 67, 3437–3443 (1999). Albeit a reactogenic strain, a single dose of SC602 protected volunteers against challenge with wild-type S. flexneri 2a.
  CAS PubMed PubMed Central Google Scholar
• Formal, S. B. et al. Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine. J. Bacteriol. 92, 17–22 (1966).
  CAS PubMed PubMed Central Google Scholar
• Formal, S. B., Maenza, R. M., Austin, S. & LaBrec, E. H. Failure of parenteral vaccines to protect monkeys against experimental shigellosis. Proc. Soc. Exp. Biol. 125, 347–349 (1967).
  Article CAS PubMed Google Scholar
• Formal, S. B. et al. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei. J. Infect. Dis. 164, 533–537 (1991). NHPs that had recovered from S. flexneri 2a challenge were protected against re-challenge with S. flexneri 2a but not against challenge with heterologous serotype S. sonnei .
  Article CAS PubMed Google Scholar
• Rout, W. R., Formal, S. B., Giannella, R. A. & Dammin, G. J. Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies. Gastroenterol. 68, 270–278 (1975). Demonstrated that NHPs experiencing Shigella diarrhoea for some hours before the onset of dysentery had net jejunal secretion, implying the action of an enterotoxin.
  CAS Google Scholar
• Kinsey, M. D., Formal, S. B., Dammin, G. J. & Giannella, R. A. Fluid and electrolyte transport in rhesus monkeys challenged intracecally with Shigella flexneri 2a. Infect. Immun. 14, 368–371 (1976).
  CAS PubMed PubMed Central Google Scholar
• Fasano, A. et al. Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro. J. Clin. Invest. 95, 2853–2861 (1995). Identification and characterization of ShET1.
  Article CAS PubMed PubMed Central Google Scholar
• Fasano, A., Noriega, F. R., Liao, F. M., Wang, W. & Levine, M. M. Effect of Shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo. Gut 40, 505–511 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Nataro, J. P. et al. Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect. Immun. 63, 4721–4728 (1995). Discovery of plasmid-encoded ShET2.
  CAS PubMed PubMed Central Google Scholar
• Noriega, F. R., Liao, F. M., Formal, S. B., Fasano, A. & Levine, M. M. Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes. J. Infect. Dis. 172, 1408–1410 (1995).
  Article CAS PubMed Google Scholar
• Nie, H. et al. Complete genome sequence of Shigella flexneri 5b and comparison with Shigella flexneri 2a. BMC Genomics 7, 173 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Yavzori, M., Cohen, D. & Orr, N. Prevalence of the genes for Shigella enterotoxins 1 and 2 among clinical isolates of Shigella in Israel. Epidemiol. Infect. 128, 533–535 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Roy, S., Thanasekaran, K., Dutta Roy, A. R. & Sehgal, S. C. Distribution of Shigella enterotoxin genes and secreted autotransporter toxin gene among diverse species and serotypes of Shigella isolated from Andaman Islands, India. Trop. Med. Int. Health 11, 1694–1698 (2006).
  Article CAS PubMed Google Scholar
• Niyogi, S. K., Vargas, M. & Vila, J. Prevalence of the sat, set and sen genes among diverse serotypes of Shigella flexneri strains isolated from patients with acute diarrhoea. Clin. Microbiol. Infect. 10, 574–576 (2004).
  Article CAS PubMed Google Scholar
• DuPont, H. L. et al. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J. Infect. Dis. 125, 12–16 (1972).
  Article CAS PubMed Google Scholar
• Oberhelman, R. et al. Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides. Infect. Immun. 59, 2341–2350 (1991).
  CAS PubMed PubMed Central Google Scholar
• Islam, D., Wretlind, B., Ryd, M., Lindberg, A. A. & Christensson, B. Immunoglobulin subclass distribution and dynamics of _Shigella_-specific antibody responses in serum and stool samples in shigellosis. Infect. Immun. 63, 2054–2061 (1995).
  CAS PubMed PubMed Central Google Scholar
• Azim, T. et al. Lipopolysaccharide-specific antibodies in plasma and stools of children with _Shigella_-associated leukemoid reaction and hemolytic–uremic syndrome. Clin. Diagn. Lab. Immunol. 3, 701–705 (1996).
  CAS PubMed PubMed Central Google Scholar
• Orr, N., Robin, G., Lowell, G. & Cohen, D. Presence of specific immunoglobulin A-secreting cells in peripheral blood after natural infection with Shigella sonnei. J. Clin. Microbiol. 30, 2165–2168 (1992).
  CAS PubMed PubMed Central Google Scholar
• Cohen, D. et al. Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination. Clin. Diagn. Lab. Immunol. 3, 451–455 (1996).
  CAS PubMed PubMed Central Google Scholar
• Van de Verg, L. et al. Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi–Shigella sonnei vaccine or infection by pathogenic S. sonnei. Infect. Immun. 58, 2002–2004 (1990).
  CAS PubMed PubMed Central Google Scholar
• Kotloff, K. L. et al. Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen. Infect. Immun. 60, 2218–2224 (1992).
  CAS PubMed PubMed Central Google Scholar
• Kotloff, K. L. et al. Evaluation of the safety, immunogenicity and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli–Shigella flexneri 2a vaccine strain EcSf2a-2. Vaccine 13, 495–502 (1995).
  Article CAS PubMed Google Scholar
• Levine, M. M., Gangarosa, E. J., Werner, M. & Morris, J. G. Shigellosis in custodial institutions. III. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated Shigella vaccine. J. Pediatr. 84, 803–806 (1974).
  Article CAS PubMed Google Scholar
• Tacket, C. O. et al. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am. J. Trop. Med. Hyg. 47, 276–283 (1992). Cow's milk immunoglobulin containing high titres of anti- Shigella antibodies protected volunteers against diarrhoeal illness following challenge with S. flexneri 2a.
  Article CAS PubMed Google Scholar
• Oaks, E. V., Hale, T. L. & Formal, S. B. Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp. Infect. Immun. 53, 57–63 (1986).
  CAS PubMed PubMed Central Google Scholar
• Van de Verg, L. L., Herrington, D. A., Boslego, J., Lindberg, A. A. & Levine, M. M. Age-specific prevalence of serum antibodies to the invasion plasmid and lipopolysaccharide antigens of Shigella species in Chilean and North American populations. J. Infect. Dis. 166, 158–161 (1992).
  Article CAS PubMed Google Scholar
• Raqib, R. et al. Dissociation between cytokine mRNA expression and protein production in shigellosis. Eur. J. Immunol. 26, 1130–1138 (1996).
  Article CAS PubMed Google Scholar
• Raqib, R. et al. Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect. Immun. 63, 289–296 (1995).
  CAS PubMed PubMed Central Google Scholar
• Raqib, R., Wretlind, B., Andersson, J. & Lindberg, A. A. Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma. J. Infect. Dis. 171, 376–384 (1995).
  Article CAS PubMed Google Scholar
• Raqib, R., Ljungdahl, A., Lindberg, A. A., Andersson, U. & Andersson, J. Local entrapment of interferon γ in the recovery from Shigella dysenteriae type 1 infection. Gut 38, 328–336 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Raqib, R. et al. Delayed and reduced adaptive humoral immune responses in children with shigellosis compared with in adults. Scand. J. Immunol. 55, 414–423 (2002).
  Article CAS PubMed Google Scholar
• Samandari, T. et al. Production of IFN-γ and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a shiga toxin-deleted Shigella dysenteriae type 1 strain. J. Immunol. 164, 2221–2232 (2000).
  Article CAS PubMed Google Scholar
• Islam, D., Bardhan, P. K., Lindberg, A. A. & Christensson, B. Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease. Infect. Immun. 63, 2941–2949 (1995).
  CAS PubMed PubMed Central Google Scholar
• Islam, D., Wretlind, B., Lindberg, A. A. & Christensson, B. Changes in the peripheral blood T-cell receptor Vβ repertoire in vivo and in vitro during shigellosis. Infect. Immun. 64, 1391–1399 (1996).
  CAS PubMed PubMed Central Google Scholar
• World Health Organization. Future needs and directions for Shigella vaccines. Wkly Epidemiol. Rec. 81, 51–58 (2006).
• Mel, D. M., Terzin, A. L. & Vuksic, L. Studies on vaccination against bacillary dysentery. 1. Immunization of mice against experimental Shigella infection. Bull. World Health Organ. 32, 633–636 (1965).
  CAS PubMed PubMed Central Google Scholar
• Mel, D. M., Papo, R. G., Terzin, A. L. & Vuksic, L. Studies on vaccination against bacillary dysentery. 2. Safety tests and reactogenicity studies on a live dysentery vaccine intended for use in field trials. Bull. World Health Organ. 32, 637–645 (1965).
  CAS PubMed PubMed Central Google Scholar
• Sereny, B. Experimental keratoconjunctivitis shigellosa. Acta Microbiol. Acad. Sci. Hung. 4, 367–376 (1957).
  CAS PubMed Google Scholar
• Mel, D. M., Terzin, A. L. & Vuksic, L. Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial. Bull. World Health Organ. 32, 647–655 (1965).
  CAS PubMed PubMed Central Google Scholar
• Mel, D. M., Arsic, B. L., Nikolic, B. D. & Radovanovic, M. L. Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines. Bull. World Health Organ. 39, 375–380 (1968). Multivalent oral Shigella vaccine protected children against shigellosis in a controlled field trial.
  CAS PubMed PubMed Central Google Scholar
• Mel, D. M., Gangarosa, E. J., Radovanovic, M. L., Arsic, B. L. & Litvinjenko, S. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains. Bull. World Health Organ. 45, 457–464 (1971). Oral SmD Shigella vaccine conferred protection for less than 1 year; a single oral booster extended protection.
  CAS PubMed PubMed Central Google Scholar
• Mel, D. M., Arsic, B. L., Radovanovic, M. L. & Litvinjenko, S. Live oral Shigella vaccine: vaccination schedule and the effect of booster dose. Acta Microbiol. Acad. Sci. Hung. 21, 109–114 (1974).
  CAS PubMed Google Scholar
• DuPont, H. L. et al. Immunity in shigellosis. I. Response of man to attenuated strains of Shigella. J. Infect. Dis. 125, 5–11 (1972).
  Article CAS PubMed Google Scholar
• Levine, M. M. et al. Shigellosis in custodial institutions. II. Clinical, immunologic and bacteriologic response of institutionalized children to oral attenuated Shigella vaccines. Am. J. Epidemiol. 96, 40–49 (1972).
  Article CAS PubMed Google Scholar
• Levine, M. M. et al. Shigellosis in custodial institutions. IV. In vivo stability and transmissibility of oral attenuated streptomycin-dependent Shigella vaccines. J. Infect. Dis. 131, 704–707 (1975).
  Article Google Scholar
• Levine, M. M., Gangarosa, E. J., Barrow, W. B. & Weiss, C. F. Shigellosis in custodial institutions. V. Effect of intervention with streptomycin-dependent Shigella sonnei vaccine in an institution with endemic disease. Am. J. Epidemiol. 104, 88–92 (1976).
  Article CAS PubMed Google Scholar
• Damjanovic, V. Freeze-drying of live oral streptomycin-dependent mutant Shigella vaccines: survival of streptomycin-dependent Shigella flexneri 2a after freeze-drying. Cryobiology 9, 565–568 (1972).
  Article CAS PubMed Google Scholar
• Meitert, T. et al. Prophylaxie de la dysenterie bacillaire par le vaccin vivant antidysentérique dans une collectivité d'enfants neuropsychiques. Arch. Roum. Path. Exp. Microbiol. 32, 35–44 (1973).
  CAS PubMed Google Scholar
• Meitert, T., Pencu, E., Ciudin, L. & Tonciu, M. Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati). Arch. Roum. Pathol. Exp. Microbiol. 43, 251–278 (1984).
  CAS PubMed Google Scholar
• Bingrui, W. Study on the effect of oral immunization of T32-Istrati strain against bacillary dysentery in field trials. Arch. Roum. Pathol. Exp. Microbiol. 43, 285–289 (1984).
  CAS PubMed Google Scholar
• Venkatesan, M., Fernandez Prada, C., Buysse, J. M., Formal, S. B. & Hale, T. L. Virulence phenotype and genetic characteristics of the T32- ISTRATI Shigella flexneri 2a vaccine strain. Vaccine 9, 358–363 (1991).
  Article CAS PubMed Google Scholar
• Tu, G. et al. Double-blind field trial of oral live F2a–Sonnei (FS) dysentery vaccine. J. Biol. Prod. 12, 178–180 (1999).
  Google Scholar
• Formal, S. B., LaBrec, E. H., Palmer, A. & Falkow, S. Protection of monkeys against experimental shigellosis with attenuated vaccines. J. Bacteriol. 90, 63–68 (1965).
  CAS PubMed PubMed Central Google Scholar
• Falkow, S., Schneider, H., Baron, L. S. & Formal, S. B. Virulence of Escherichia–Shigella genetic hybrids for the guinea pig. J. Bacteriol. 86, 1251–1258 (1963).
  CAS PubMed PubMed Central Google Scholar
• Li, A. et al. Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers. Vaccine 11, 180–189 (1993).
  Article CAS PubMed Google Scholar
• Lindberg, A. A., Karnell, A. & Stocker, B. A. D. in Aromatic-Dependent Shigella Strains as Oral Live Vaccines (eds. Woodrow, G. C. & Levine, M. M.) 677–687 (Marcel Dekker, New York, 1990).
  Google Scholar
• Karnell, A. et al. Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers. Vaccine 13, 88–89 (1995).
  Article CAS PubMed Google Scholar
• Kotloff, K. L. et al. Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infect. Immun. 64, 4542–4548 (1996).
  CAS PubMed PubMed Central Google Scholar
• Kotloff, K. L. et al. Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans. Infect. Immun. 68, 1034–1039 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Kotloff, K. L. et al. Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a Phase 1 trial of CVD 1204 and CVD 1208. J. Infect. Dis. 190, 1745–1754 (2004). This randomized, double-blind clinical trial confirmed that ShET1 and ShET2 cause diarrhoea.
  Article CAS PubMed Google Scholar
• Katz, D. E. et al. Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers. Infect. Immun. 72, 923–930 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Noriega, F. R. et al. Construction and characterization of attenuated Δ_aroA_ Δ_virG Shigella flexneri_ 2a strain CVD 1203, a prototype live oral vaccine. Infect. Immun. 65, 5168–5172 (1994).
  Google Scholar
• Noriega, F. R. et al. Engineered Δ_guaB-A_, Δ_virG Shigella flexneri_ 2a strain CVD 1205: construction, safety, immunogenicity and potential efficacy as a mucosal vaccine. Infect. Immun. 64, 3055–3061 (1996).
  CAS PubMed PubMed Central Google Scholar
• Hartman, A. B. & Venkatesan, M. M. Construction of a stable attenuated Shigella sonnei Δ_virG_ vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model. Infect. Immun. 66, 4572–4576 (1998).
  CAS PubMed PubMed Central Google Scholar
• Black, R. E. et al. Prevention of shigellosis by a Salmonella typhi–Shigella sonnei bivalent vaccine. J. Infect. Dis. 155, 1260–1265 (1987). Two pilot lots of this live vector vaccine conferred protection against challenge with S. sonnei , whereas other lots did not.
  Article CAS PubMed Google Scholar
• Kotloff, K. et al. Phase 1 evaluation of a vriG deleted Shigella sonnei live, attenuated vaccine (strain WRSS1) in healthy adult volunteers. Infect. Immun. 70, 2016–2021 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Orr, N. et al. Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers. Infect. Immun. 73, 8027–8032 (2005). An engineered S. sonnei strain was mildly reactogenic and moderately immunogenic in adults.
  Article CAS PubMed PubMed Central Google Scholar
• Newland, J. W., Hale, T. L. & Formal, S. B. Genotypic and phenotypic characterization of an aroD deletion-attenuated Escherichia coli K12–Shigella flexneri hybrid vaccine expressing S. flexneri 2a somatic antigen. Vaccine 10, 766–776 (1992).
  Article CAS PubMed Google Scholar
• Formal, S. B. et al. Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain. Infect. Immun. 34, 746–750 (1981).
  CAS PubMed PubMed Central Google Scholar
• Tramont, E. C. et al. Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076–1C). J. Infect. Dis. 149, 133–136 (1984).
  Article CAS PubMed Google Scholar
• Seid, R. C. et al. Unusual lipopolysaccharide antigens of a Salmonella typhi oral vaccine strain expressing the Shigella sonnei form I antigen. J. Biol. Chem. 259, 9028–9034 (1984).
  CAS PubMed Google Scholar
• Schultz, C. L. et al. Cell wall structures which may be important for successful immunization with Salmonella–Shigella hybrid vaccines. Vaccine 8, 115–120 (1990).
  Article CAS PubMed Google Scholar
• Hartman, A. B., Ruiz, M. M. & Schultz, C. L. Molecular analysis of variant plasmid forms of a bivalent Salmonella typhi–Shigella sonnei vaccine strain. J. Clin. Microbiol. 29, 27–32 (1991).
  CAS PubMed PubMed Central Google Scholar
• Hartman, A. B., Powell, C. J., Schultz, C. L., Oaks, E. V. & Eckels, K. H. Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains. Infect. Immun. 59, 4075–4083 (1991).
  CAS PubMed PubMed Central Google Scholar
• Xu, D. Q., Cisar, J. O., Ambulos, J. N., Jr, Burr, D. H. & Kopecko, D. J. Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live Salmonella vaccine vector. Infect. Immun. 70, 4414–4423 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• John, T. J. Immunisation against polioviruses in developing countries. Rev. Med. Virol. 3, 149–160 (1993).
  Article Google Scholar
• Hanlon, P. et al. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1, 1342–1345 (1987).
  Article CAS PubMed Google Scholar
• Suharyono et al. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5–9-year-old Indonesian children. Lancet 340, 689–694 (1992).
  Article CAS PubMed Google Scholar
• Hallander, H. O. et al. Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children. Vaccine 21, 138–145 (2002).
  Article CAS PubMed Google Scholar
• Li, A. et al. Immune responses in Vietnamese children after a single dose of the auxotrophic, live Shigella flexneri Y vaccine strain SFL124. J. Infect. 28, 11–23 (1994). An aroD mutant S. flexneri Y strain stimulated ASC responses in Vietnamese children.
  Article CAS PubMed Google Scholar
• Robbins, J. B., Chu, C. & Schneerson, R. Hypothesis for vaccine development: protective immunity to enteric diseases caused by non-typhoidal Salmonellae and Shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharides of their lipopolysaccharides. Clin. Infect. Dis. 15, 346–351 (1992).
  Article CAS PubMed Google Scholar
• Chowers, Y. et al. Specific polysaccharide conjugate vaccine-induced IgG antibodies prevent invasion of Shigella into Caco-2 cells and may be curative. Proc. Natl Acad. Sci. USA 104, 2396–2401 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Cohen, D., Green, M. S., Block, C., Slepon, R. & Ofek, I. Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis. J. Clin. Microbiol. 29, 386–389 (1991). Soldiers with elevated titres of Shigella O-antigen antibodies had lower attack rates of shigellosis than sero-negative soldiers upon natural exposure in the field.
  CAS PubMed PubMed Central Google Scholar
• Cohen, D., Green, M. S., Block, C., Rouach, T. & Ofek, I. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population. J. Infect. Dis. 157, 1068–1071 (1988).
  Article CAS PubMed Google Scholar
• Cohen, D. et al. Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers. Infect. Immun. 64, 4074–4077 (1996).
  CAS PubMed PubMed Central Google Scholar
• Cohen, D. et al. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Lancet 349, 155–159 (1997). An S. sonnei conjugate vaccine protected young adult soldiers against S. sonnei shigellosis under conditions of natural exposure in the field.
  Article CAS PubMed Google Scholar
• Ashkenazi, S. et al. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children. J. Infect. Dis. 179, 1565–1568 (1999).
  Article CAS PubMed Google Scholar
• Passwell, J. H. et al. Safety and immunogenicity of _Shigella sonnei_-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children. Pediatr. Infect. Dis. J. 22, 701–706 (2003).
  Article PubMed Google Scholar
• Phalipon, A. et al. Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine. J. Immunol. 176, 1686–1694 (2006).
  Article CAS PubMed Google Scholar
• Noriega, F. R. et al. Strategy for cross-protection among Shigella flexneri serotypes. Infect. Immun. 67, 782–788 (1999). In the guinea pig keratoconjunctivitis model, a bivalent mucosal vaccine consisting of attenuated S. flexneri 2a and S. flexneri 3a strains conferred significant cross-protection against challenge with multiple other S. flexneri subserotypes.
  CAS PubMed PubMed Central Google Scholar
• Lindberg, A. A., Karnell, A. & Weintraub, A. The lipopolysaccharide of Shigella bacteria as a virulence factor. Rev. Infect. Dis. 13 (Suppl. 4), S279–S284 (1991).
  Article CAS PubMed Google Scholar
• West, N. P. et al. Optimization of virulence functions through glucosylation of Shigella LPS. Science. 307, 1313–1317 (2005).
  Article CAS PubMed Google Scholar
• Carlin, N. I., Wehler, T. & Lindberg, A. A. Shigella flexneri O-antigen epitopes: chemical and immunochemical analyses reveal that epitopes of type III and group 6 antigens are identical. Infect. Immun. 53, 110–115 (1986).
  CAS PubMed PubMed Central Google Scholar
• Carlin, N. I. et al. Use of monoclonal antibodies to type Shigella flexneri in Bangladesh. J. Clin. Microbiol. 27, 1163–1166 (1989).
  CAS PubMed PubMed Central Google Scholar
• Feng, L. et al. Structural and genetic evidence that the Escherichia coli O148 O antigen is the precursor of the Shigella dysenteriae type 1 O antigen and identification of a glucosyltransferase gene. Microbiology 153, 139–147 (2007).
  Article CAS PubMed Google Scholar
• Fries, L. F. et al. Safety and immunogenicity of a proteosome — Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults. Infect. Immun. 69, 4545–4553 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• McKenzie, R. et al. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial. Vaccine 24, 3735–3745 (2006).
  Article CAS PubMed Google Scholar
• Oaks, E. V. & Turbyfill, K. R. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine. Vaccine 24, 2290–2301 (2006).
  Article CAS PubMed Google Scholar
• Levenson, V. et al. Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine. Infect. Immun. 59, 3610–3618 (1991).
  CAS PubMed PubMed Central Google Scholar
• D'Hauteville, H. et al. Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium. J. Immunol. 168, 5240–5251 (2002).
  Article CAS PubMed Google Scholar
• Prado, V. et al. Population-based study of the incidence of Shigella diarrhea and causative serotypes in Santiago, Chile. Pediatr. Infect. Dis. J. 18, 500–505 (1999).
  Article CAS PubMed Google Scholar
• Ahmed, S. F. et al. Epidemiology and genetic characterization of Shigella flexneri strains isolated from three paediatric populations in Egypt (2000–2004). Epidemiol. Infect. 134, 1237–1248 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Cohen, D., Green, M. S., Block, C., Slepon, R. & Lerman, Y. Natural immunity to shigellosis in two groups with different previous risks of exposure to Shigella is only partly expressed by serum antibodies to lipopolysaccharide. J. Infect. Dis. 165, 785–787 (1992).
  Article CAS PubMed Google Scholar